Advanced Glycation Endproducts Induce Changes in Glucose Consumption, Lactate Production, and ATP Levels in SH-SY5Y Neuroblastoma Cells by a Redox-Sensitive Mechanism

Journal of Cerebral Blood Flow and Metabolism

Volumn 23, Issue 11, 2003, Pages 1307-1313

  De Arriba, Susana Garcia ^a   Loske, Claudia ^d   Meiners, Ina ^a   Fleischer, Gerd ^a   Lobisch, Michael ^b   Wessel, Klaus ^b   Tritschler, Hans ^b   Schinzel, Reinhard ^d   Münch, Gerald ^a,c  

^a Neuroimmunological Cell Biology Unit   (Germany)

^b Viatris Inc   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d NONE

Author keywords

Advanced glycation endproducts; Antioxidants; Lactate; Lipoic acid; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; ANTIOXIDANT; ESTRADIOL; GLUCOSE; LACTIC ACID; THIOCTIC ACID;

ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CELL ENERGY; CONTROLLED STUDY; ENERGY YIELD; GLUCOSE INTAKE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROBLASTOMA CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0242658561     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000090622.86921.0E     Document Type: Article

References (37)

1. Adair JC, Knoefel JE, Morgan N (2001) Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology 57:1515-1517
2. Ayres S, Abplanalp W, Liu JH, Subbiah MT (1998) Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage. Am J Physiol 274:E1002-E1008
3. Behl C, Moosmann B (2002) Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach(2). Free Radic Biol Med 33:182-191
4. Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Ann Rev Med 46:223-234
5. Gasic-Milenkovic J, Loske C, Deuther-Conrad W, Münch G (2001) Protein 'AGEing'-cytotoxicity of a glycated protein increases with its degree of AGE-modification. Z Gerontol Geriatr 34:457-460
6. Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames AB (1999) (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. Faseb J 13:411-418
7. Hager K, Marahrens A, Kenklies M, Riederer P, Münch G (2001) Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Arch Gerontol Geriatr 32:275-282
8. Humphries KM, Szweda LI (1998) Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37:15835-15841
9. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide - role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284
10. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH (1999) Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22:280-287
11. Krishnamurthy PK, Mays JL, Bijur GN, Johnson GV (2000) Transient oxidative stress in SH-SY5Y human neuroblastoma cells results in caspase dependent and independent cell death and tau proteolysis. J Neurosci Res 61:515-523
12. Liu BF, Miyata S, Kojima H, Uriuhara A, Kusunoki H, Suzuki K, Kasuga M (1999) Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 48:2074-2082
13. Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, Münch G (1998) Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105:1005-1015
14. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, Wallace DC (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96:846-851
15. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H (1994a) Involvement of beta(2)-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis - induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Investig 93:521-528
16. Miyata T, Inagi R, Wada Y, Ueda Y, Iida Y, Takahashi M, Taniguchi N, Maeda K (1994b) Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. Biochemistry 33:12215-12221
17. Miyazaki A, Nakayama H, Horiuchi S (2002) Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 12:258-262
18. Nath R, Raser KJ, Hajimohammadreza I, Wang KK (1997) Thapsigargin induces apoptosis in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. Biochem Mol Biol Int 43:197-205
19. Nickander KK, McPhee BR, Low PA, Tritschler H (1996) Alpha-lipoic acid - antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Rad Biol Med 21:631-639
20. Ortwerth BL, James H, Simpson G, Linetsky M (1998) The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones. Biochemical Biophys Res Commun 245: 161-165
21. Packer L, Witt EH, Tritschler HJ (1995) alpha-Lipoic acid as a biological antioxidant. Free Rad Biol Med 19:227-250
22. Parnetti L, Gaiti A, Polidori MC, Brunetti M, Palumbo B, Chionne F, Cadini D, Cecchetti R, Senin U (1995) Increased cerebrospinal fluid pyruvate levels in Alzheimers disease. Neurosci Lett 199: 231-233
23. Peter G, Borbe HO (1996) Untersuchungen zur Absorption und Verfügbarkeit der Thioctsaäure als Grundlage der klinischen Wirksamkeit der Behandlung der diabetischen Polyneuropathie. Diabetes Stoffwechsel 5 (Suppl):12-16
24. Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL (1998) Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology 44:300-304
25. Römer W, Oettel M, Droescher P, Schwarz S (1997) Novel "scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol. Steroids 62:304-310
26. Rosak C, Höffken P, Baltes W, Drinda H, Ulrich H, Tritschler HJ, Etze M, Blume (1996) Untersuchungen zur Biofverfügbarkeit von alpph Liponsäure (Thioctsäure) bei Typ i und Typ p Diabetikern mit diebtischer Polyneuropathy. Diabetes Stoffwechsel 3 (Suppl): 23-26
27. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z (1998) Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 153:1149-1155
28. Saxena P, Saxena AK, Cui XL, Obrenovich M, Gudipaty K, Monnier VM (2000) Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci 41:1473-1481
29. Shapira R, Austin GE, Mirra SS (1988) Neuritic plaque amyloid in Alzheimer's disease is highly racemized. J Neurochem 50:69-74
30. Thurston JH, McDougal DB, Hauhart RE, Schulz DW (1995) Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve - relation to mechanisms of peripheral neuropathy. Diabetes 44:190-195
31. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 91:4766-4770
32. Wagner Z, Wittmann I, Mazak I, Schinzel R, Heidland A, Kientsch-Engel R, Nagy J (2001) N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis 38:785-791
33. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694
34. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813
35. Yan SD, Schmidt AM, Anderson GM, Zhang JH, Brett J, Zou YS, Pinsky D, Stern D (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors binding proteins. J Biol Chem 269:9889-9897
36. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, et al. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1:693-699
37. Zhong J, Iqbal K, Grundke-Iqbal I (1999) Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain. FEBS Lett 453:224-228